Ghrelin O-acyltransferase inhibitors
This invention relates to novel compounds according to Formula (I) which are inhibitors of ghrelin O-acyltransferase (GOAT), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy for the treatment of metabolic disorders (e.g. Prader-Willi syn...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English |
Published |
26.04.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | This invention relates to novel compounds according to Formula (I) which are inhibitors of ghrelin O-acyltransferase (GOAT), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy for the treatment of metabolic disorders (e.g. Prader-Willi syndrome, metabolic syndrome, insulin resistance, impaired glucose tolerance, prediabetes, diabetes mellitus (e.g., type II diabetes mellitus), dysglycemia (e.g., hyperglycemia), obesity (e.g., obesity caused by Prader-Willi syndrome), increased adiposity, poor glycemic control, hyperphagia, impaired satiety, dyslipidemia (e.g., atherogenic dyslipidemia), hepatic steatosis (e.g., non-alcoholic fatty liver disease (e.g., non-alcoholic steatohepatitis))), psychiatric disorders (e.g., eating disorders (e.g., bulimia nervosa, binge eating disorder, night-time eating syndrome), substance related disorders (e.g., addiction disorders (e.g., alcohol, smoking, overeating, or use of illicit drugs))), as well as disorders related to or complications of metabolic or psychiatric disorders (e.g., cardiovascular diseases (e.g., diabetic heart disease (e.g., diabetic cardiomyopathy), heart failure, or hypertension), ischemia (e.g., myocardial ischemia, cerebral ischemia, ischemic stroke), or BMI-related cancers (e.g., pancreatic cancer, gallbladder cancer, esophageal cancer, colorectal cancer, breast cancer etc.). |
---|---|
AbstractList | This invention relates to novel compounds according to Formula (I) which are inhibitors of ghrelin O-acyltransferase (GOAT), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy for the treatment of metabolic disorders (e.g. Prader-Willi syndrome, metabolic syndrome, insulin resistance, impaired glucose tolerance, prediabetes, diabetes mellitus (e.g., type II diabetes mellitus), dysglycemia (e.g., hyperglycemia), obesity (e.g., obesity caused by Prader-Willi syndrome), increased adiposity, poor glycemic control, hyperphagia, impaired satiety, dyslipidemia (e.g., atherogenic dyslipidemia), hepatic steatosis (e.g., non-alcoholic fatty liver disease (e.g., non-alcoholic steatohepatitis))), psychiatric disorders (e.g., eating disorders (e.g., bulimia nervosa, binge eating disorder, night-time eating syndrome), substance related disorders (e.g., addiction disorders (e.g., alcohol, smoking, overeating, or use of illicit drugs))), as well as disorders related to or complications of metabolic or psychiatric disorders (e.g., cardiovascular diseases (e.g., diabetic heart disease (e.g., diabetic cardiomyopathy), heart failure, or hypertension), ischemia (e.g., myocardial ischemia, cerebral ischemia, ischemic stroke), or BMI-related cancers (e.g., pancreatic cancer, gallbladder cancer, esophageal cancer, colorectal cancer, breast cancer etc.). |
Author | Bandyopadhyay, Anish Su, Dai-Shi Cheung, Mui Eidam, Hilary Schenck Joshi, Hemant |
Author_xml | – fullname: Eidam, Hilary Schenck – fullname: Cheung, Mui – fullname: Joshi, Hemant – fullname: Su, Dai-Shi – fullname: Bandyopadhyay, Anish |
BookMark | eNrjYmDJy89L5WRQcc8oSs3JzFPw101MrswpKUrMK05LLUosTlXIzMvITMosyS8q5mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8aHBhobGhkbmBpZORsbEqAEADv0o9A |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | US11312709B2 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_US11312709B23 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 15:14:32 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_US11312709B23 |
Notes | Application Number: US201916967262 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220426&DB=EPODOC&CC=US&NR=11312709B2 |
ParticipantIDs | epo_espacenet_US11312709B2 |
PublicationCentury | 2000 |
PublicationDate | 20220426 |
PublicationDateYYYYMMDD | 2022-04-26 |
PublicationDate_xml | – month: 04 year: 2022 text: 20220426 day: 26 |
PublicationDecade | 2020 |
PublicationYear | 2022 |
RelatedCompanies | Glaxosmithkline Intellectual Property Development Limited |
RelatedCompanies_xml | – name: Glaxosmithkline Intellectual Property Development Limited |
Score | 3.4022784 |
Snippet | This invention relates to novel compounds according to Formula (I) which are inhibitors of ghrelin O-acyltransferase (GOAT), to pharmaceutical compositions... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
Title | Ghrelin O-acyltransferase inhibitors |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220426&DB=EPODOC&locale=&CC=US&NR=11312709B2 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1NS8Mw9DGmqDedis4PKozeil2atc2hCP1yCFuHW2W3YdIUK1LHVhH_vS-lc170FhJ4SR687y-AnjS5LYXyaziUGzTPmMEyhxnUFWxABBFOpvyQo7E9TOnDfDBvweumFqbuE_pZN0dEihJI71XNr5dbJ1ZY51aub3mBW-938cwL9cY6JkSZBHroe9EkCZNADwIvnerjR6_ft1SMlfnIrneUGq367EdPvqpKWf4WKfEh7E4QWlkdQUuWHdgPNpPXOrA3agLeuGxob30MvXtEOyqFWmI8i6-3qtY45QqlkFaULwUv1NycE7iJo1kwNPC6xc_fFul0-zLrFNpo88sz0HLCuMkk59SUlNPcpdQhUkjKMsJc1zqH7t9wuv8dXsCBwpMKiBD7EtrV6kNeoVyt-HWNkG8zUHw9 |
link.rule.ids | 230,309,786,891,25594,76906 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1NS8Mw9DGmOG86FZ1fFUZvxS3N2uZQhLarVdd2uFZ2GyZNsSJ1bBXx35uUzXnRW0jgJXnwvr8AurxHDc6kX8PEVMN5RjSSmUTDFiMDxBAzM-mHDCMjSPH9dDBtwOu6FqbuE_pZN0cUFMUEvVc1v55vnFhenVu5vKaF2Hq_8RPbU1fWMULSJFA9xx6OYy92Vde104kaPdr9vi5jrMQR7HrLlN15per05MiqlPlvkeLvwfZYQCurfWjwsg0tdz15rQ074SrgLZYr2lseQPdWoF0ohUqsPbOvt6rWOPlCSCGlKF8KWsi5OYdw5Q8TN9DEdbOfv83SyeZl-hE0hc3Pj0HJEaE9winFPY4pzi2MTcQZxyRDxLL0E-j8Dafz3-EltIIkHM1Gd9HDKexKnMngCDLOoFktPvi5kLEVvaiR8w0qtn8q |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Ghrelin+O-acyltransferase+inhibitors&rft.inventor=Eidam%2C+Hilary+Schenck&rft.inventor=Cheung%2C+Mui&rft.inventor=Joshi%2C+Hemant&rft.inventor=Su%2C+Dai-Shi&rft.inventor=Bandyopadhyay%2C+Anish&rft.date=2022-04-26&rft.externalDBID=B2&rft.externalDocID=US11312709B2 |